This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Malignant Melanoma
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Studies in animals and retrospective studies in humans show that regional anesthesia reduces metastatic cancer dissemination. The investigators hypothesize that in patients suffering from malignant melanoma who have to undergo radical inguinal lymph node dissection immune function will be less compromised and long term survival will be superior when spinal anesthesia is compared to general anesthesia.

Provided treatments

  • Procedure: Spinal anesthesia with Bupivacaine hyperbar 0.5 %
  • Procedure: General anesthesia with Sufentanil, Propofol and Rocuronium and Sevoflurane

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01588847. The sponsor of the trial is University Hospital Muenster and it is looking for 230 volunteers for the current phase.
Official trial title:
Long-term Outcome After Radical Lymph Node Dissection of Malignant Melanoma. Comparison Between Regional Versus General Anesthesia With Respect to Impact of Perioperative Immunoediting and Validation of New Potential Predictive Biomarkers